Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Vazquez Mena, Oscar ^a   Medina Martinez, Ingrid ^a   Juárez Torres, Eligia ^a   Barrón, Valeria ^a   Espinosa, Ana ^a   Villegas Sepulveda, Nicolás ^b   Gómez Laguna, Laura ^a   Nieto Martínez, Karem ^a   Orozco, Lorena ^c   Roman Basaure, Edgar ^d   Muñoz Cortez, Sergio ^d   Borges Ibañez, Manuel ^d   Venegas Vega, Carlos ^a   Guardado Estrada, Mariano ^a   Rangel López, Angélica ^e   Kofman, Susana ^a   Berumen, Jaime ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; COPY NUMBER VARIATION; DEREGULATION; DOWN REGULATION; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; HELA CELL; HUMAN; HUMAN CELL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; CELL LINE; CHROMOSOME ABERRATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; MOLECULAR GENETICS; SIGNAL TRANSDUCTION; UTERINE CERVIX TUMOR;

CELL LINE; CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MOLECULAR SEQUENCE ANNOTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 84857856392     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032667     Document Type: Article

References (59)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-7108.
2. Yugawa T, Kiyono T, (2009) Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 19: 97-113.
3. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, et al. (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633-1638.
4. Dellas A, Torhorst J, Jiang F, Proffitt J, Schultheiss E, et al. (1999) Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. Cancer Res 59: 3475-3479.
5. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, et al. (1999) Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 24: 144-150.
6. Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, et al. (1997) Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 19: 233-240.
7. Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, et al. (2000) Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 83: 1659-1663.
8. Matthews CP, Shera KA, McDougall JK, (2000) Genomic changes and HPV type in cervical carcinoma. Proc Soc Exp Biol Med 223: 316-321.
9. Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, et al. (2004) Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4: 5.
10. Huang FY, Kwok YKY, Lau ET, Tang MHY, Ng TY, et al. (2005) Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. Cancer Genet Cytogenet 157: 42-48.
11. Thein A, Trkova M, Fox M, Parrington J, (2000) The application of comparative genomic hybridization to previously karyotyped cervical cancer cell lines. Cancer Genet Cytogenet 116: 59-65.
12. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, et al. (2002) Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 33: 98-102.
13. Dowen SE, Neutze DM, Pett MR, Cottage A, Stern P, et al. (2003) Amplification of chromosome 5p correlates with increased expression of Skp2 in HPV-immortalized keratinocytes. Oncogene 22: 2531-2540.
14. Harris CP, Lu XY, Narayan G, Singh B, Murty VV, et al. (2003) Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 36: 233-241.
15. Hidalgo A, Monroy A, Arana RM, Taja L, Vazquez G, et al. (2003) Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines. BMC Cancer 3: 8.
16. Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, et al. (2007) Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. BMC Genomics 8: 53.
17. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, et al. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A 107: 18545-18550.
18. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, et al. (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 93: 479-484.
19. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G, (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25: 195-204.
20. Mitra AB, Murty VV, Singh V, Li RG, Pratap M, et al. (1995) Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. J Natl Cancer Inst 87: 742-745.
21. Atkin NB, (2000) Significance of chromosome 5 and 17 changes in the development of carcinoma of the cervix uteri. Cytogenet Cell Genet 91: 44-46.
22. Scotto L, Narayan G, Nandula SV, Subramaniyam S, Kaufmann AM, et al. (2008) Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol Cancer 7: 58.
23. Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, et al. (2000) Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 117: 9-18.
24. Adamowicz M, Radlwimmer B, Rieker RJ, Mertens D, Schwarzbach M, et al. (2006) Frequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer 45: 829-838.
25. Belloni E, Veronesi G, Micucci C, Javan S, Minardi SP, et al. (2011) Genomic characterization of asymptomatic CT-detected lung cancers. Oncogene 30: 1117-1126.
26. Andersson S, Wallin KL, Hellstrom AC, Morrison LE, Hjerpe A, et al. (2006) Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer 95: 331-338.
27. Alameda F, Espinet B, Corzo C, Munoz R, Bellosillo B, et al. (2009) 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases. Hum Pathol 40: 1474-1478.
28. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, et al. (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19: 2739-2744.
29. Macville M, Schrock E, Padilla-Nash H, Keck C, Ghadimi BM, et al. (1999) Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 59: 141-150.
30. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, et al. (2007) Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 46: 373-384.
31. Wilting SM, de Wilde J, Meijer CJ, Berkhof J, Yi Y, et al. (2008) Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 47: 890-905.
32. Bertelsen BI, Steine SJ, Sandvei R, Molven A, Laerum OD, (2006) Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation. Int J Cancer 118: 1877-1883.
33. Lyng H, Brovig RS, Svendsrud DH, Holm R, Kaalhus O, et al. (2006) Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics 7: 268.
34. Wang H, Huang S, Shou J, Su EW, Onyia JE, et al. (2006) Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data. BMC Genomics 7: 166.
35. van Staveren WC, Solis DY, Hebrant A, Detours V, Dumont JE, et al. (2009) Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta 1795: 92-103.
36. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, et al. (2009) Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4: e6146.
37. Huang FY, Chiu PM, Tam KF, Kwok YK, Lau ET, et al. (2006) Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer. Gynecol Oncol 103: 219-225.
38. Sproul D, Gilbert N, Bickmore WA, (2005) The role of chromatin structure in regulating the expression of clustered genes. Nat Rev Genet 6: 775-781.
39. de Wit E, van Steensel B, (2009) Chromatin domains in higher eukaryotes: insights from genome-wide mapping studies. Chromosoma 118: 25-36.
40. Zheng M, Simon R, Mirlacher M, Maurer R, Gasser T, et al. (2004) TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol 165: 63-69.
41. Oshimori N, Li X, Ohsugi M, Yamamoto T, (2009) Cep72 regulates the localization of key centrosomal proteins and proper bipolar spindle formation. Embo J 28: 2066-2076.
42. Kang JU, Koo SH, Kwon KC, Park JW, Kim JM, (2008) Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 182: 1-11.
43. Snijders PJ, van Duin M, Walboomers JM, Steenbergen RD, Risse EK, et al. (1998) Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res 58: 3812-3818.
44. Henrichsen CN, Chaignat E, Reymond A, (2009) Copy number variants, diseases and gene expression. Hum Mol Genet 18: R1-8.
45. Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den Ijssel PR, et al. (2006) Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 209: 220-230.
46. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
47. Srougi MC, Burridge K, (2011) The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage. PLoS One 6: e17108.
48. Justilien V, Fields AP, (2009) Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene 28: 3597-3607.
49. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS, (2010) A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 10: 59-64.
50. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, et al. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263.
51. Peralta-Leal A, Rodriguez MI, Oliver FJ, (2008) Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment. Clin Transl Oncol 10: 318-323.
52. Arechaga-Ocampo E, Pereira-Suarez AL, del Moral-Hernandez O, Cedillo-Barron L, Rodriguez-Sastre MA, et al. (2008) HPV+ cervical carcinomas and cell lines display altered expression of caspases. Gynecol Oncol 108: 10-18.
53. Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, et al. (2001) Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. Cancer Res 61: 6281-6289.
54. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
55. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
56. Barch M, Knutsen T, (1997) The AGT cytogenetics laboratory manual Lippincott-Raven Publishers.
57. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
58. Huang DW, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
59. Kim SY, Volsky DJ, (2005) PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6: 144.